News

Barclays Maintains Equal-Weight on Amrize, Lowers Price Target to $40

Barclays analyst Adam Seiden maintains Amrize (NYSE:AMRZ) with a Equal-Weight and lowers the price target from $55 to $40.

Benzinga·10:50AMRZ▲+2.9%

Amrize (AMRZ) Benefits from Regional Scale, Tight Supply Dynamics, and Pricing Power

Harris Oakmark recently released its third-quarter 2026 investor letter for its “Oakmark Global Select Fund”. It is a non-diversified fund that focuses on long-term capital appreciation by investing in common stocks of U.S. and non-U.S. companies. The letter can be downloaded here. The Fund (Investor Class) returned 5.14% for the quarter, surpassing the MSCI World […]

Yahoo·11:45AMRZ▲+2.9%

Amrize Announces Date for Third Quarter 2026 Financial Results

CHICAGO & ZUG, Switzerland, October 14, 2026--Amrize (AMRZ) will release its third quarter 2026 financial results after the U.S. market closes on Wednesday, October 28, 2026, followed by a live webcast to discuss the company’s financial results at 7:30 am Central Time on Thursday, October 29, 2026.

Yahoo·09:00AMRZ▲+2.9%

JP Morgan Maintains Neutral on Amrize, Lowers Price Target to $48

JP Morgan analyst Adrian Huerta maintains Amrize (NYSE:AMRZ) with a Neutral and lowers the price target from $52 to $48.

Benzinga·10:13AMRZ▲+2.9%

RBC Capital Maintains Underperform on Amrize, Lowers Price Target to $32

RBC Capital analyst Anthony Codling maintains Amrize (NYSE:AMRZ) with a Underperform and lowers the price target from $48 to $32.

Benzinga·09:19AMRZ▲+2.9%

Amrize: Priced For Scant EBITDA Growth, Upside Hinges On 2027 Margin Recovery

Amrize stock is a "Hold" since its valuation implies low EBITDA growth. Learn more about the insider buying and upside potential.

SeekingAlpha·12:14AMRZ▲+2.9%

Asurion Names Baris Oran Chief Financial Officer

Asurion, a global leader in technology protection and support, today announced that Baris Oran has been named Chief Financial Officer, effective October 15, 2026. Oran will join Asurion's Executive Committee and report to Chief Executive Officer Guru Gowrappan.

Yahoo·12:00

Wells Fargo Maintains Equal-Weight on Amrize, Lowers Price Target to $40

Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Equal-Weight and lowers the price target from $44 to $40.

Benzinga·06:30AMRZ▲+2.9%

Truist Securities Maintains Hold on Amrize, Lowers Price Target to $35

Truist Securities analyst Keith Hughes maintains Amrize (NYSE:AMRZ) with a Hold and lowers the price target from $48 to $35.

Benzinga·05:23AMRZ▲+2.9%

Barclays Initiates Coverage On Amrize with Equal-Weight Rating, Announces Price Target of $55

Barclays analyst Adam Seiden initiates coverage on Amrize (NYSE:AMRZ) with a Equal-Weight rating and announces Price Target of $55.

Benzinga·04:23AMRZ▲+2.9%

Bear of the Day: Amrize (AMRZ)

Amrize (AMRZ) shares have been under considerable pressure as investors reassess the building-materials company's earnings trajectory, margins, and execution.

Yahoo·03:00AMRZ▲+2.9%

New Strong Sell Stocks for September 29th

APLD, CVCO and AMRZ have been added to the Zacks Rank #5 (Strong Sell) List on September 29, 2026.

Yahoo·04:41AMRZ▲+2.9%

Deutsche Bank Maintains Buy on Amrize, Lowers Price Target to $56

Deutsche Bank analyst Jon Bell maintains Amrize (NYSE:AMRZ) with a Buy and lowers the price target from $64 to $56.

Benzinga·09:38AMRZ▲+2.9%

Amrize's 2027 Outlook Seen Improving After Weak 2026, UBS Says

Amrize's (AMRZ) 2027 period should be better than 2026, with earnings growth returning to its mid-te

Yahoo·12:13AMRZ▲+2.9%

UBS Maintains Neutral on Amrize, Lowers Price Target to $42

UBS analyst Julian Radlinger maintains Amrize (NYSE:AMRZ) with a Neutral and lowers the price target from $57 to $42.

Benzinga·06:34AMRZ▲+2.9%

Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $55

Oppenheimer analyst Bryan Blair maintains Amrize (NYSE:AMRZ) with a Outperform and lowers the price target from $62 to $55.

Benzinga·04:56AMRZ▲+2.9%

Amrize (SWX:AMRZ) Stock Looks Below Fair Value After 28% Fall

Amrize shares have dropped sharply so far this year, which puts the focus squarely on whether the current price is still aligned with the cash the business is expected to generate over time. With the stock now trading well below where it started the year, the central question is how that market move lines up with the intrinsic value suggested by its cash flows. Year to date, Amrize has fallen 28.5%, which puts recent price weakness directly up against what its underlying cash flows may be...

Yahoo·01:14AMRZ▲2.9%

Is Amrize (SWX:AMRZ) Undervalued As Leadership Changes Test Its Turnaround Story?

Amrize (SWX:AMRZ) is back in focus after the board appointed Mario Gross as President, Building Envelope, following Jake Gosa’s resignation and year-long notice period. Recent trading tells a cautious story. Amrize’s share price has slipped to CHF31.82, with the 30-day share price return down 11.93% and the year-to-date move down 28.49%. The 1-year total shareholder return is down 21.85%, pointing to fading momentum despite insider buying and upcoming conference exposure. See how Amrize...

Yahoo·16:11AMRZ▲+2.9%

Amrize CEO Jan Philipp Jenisch Buys 30,000 Shares for $1.3 Million. Is This a Buy Signal?

Insider purchase signals confidence despite 18% one-year decline. Jenisch now holds ~2.3 million shares, representing 0.41% ownership in construction materials company.

Yahoo·20:02AMRZ▲+2.9%

Do Options Traders Know Something About Amrize Stock We Don't?

Investors need to pay close attention to AMRZ stock based on the movements in the options market lately.

Yahoo·09:54AMRZ▲+2.9%

Amrize Appoints Mario Gross as President of Building Envelope

CHICAGO & ZUG, Switzerland, September 11, 2026--The Amrize (NYSE: AMRZ) Board of Directors has appointed Mario Gross as President, Building Envelope, effective September 11, 2026. Gross succeeds Jake Gosa, who is stepping down from the role and is committed to a smooth transition.

Yahoo·16:15AMRZ▲+2.9%

Alpha Buying: 4 Falling Knives Insiders Are Buying

There are dozens of reasons corporate executives sell shares. They may need money to pay taxes, buy a house, settle a divorce, diversify their wealth, or fund a new boat they will use three times before deciding they

Benzinga·08:16

Amrize (AMRZ) Q2 2026 Earnings Call Transcript

Data center demand lifts cement and roofing volumes as oil inflation pressures margins.

Yahoo·20:01AMRZ▲+2.9%

Stephens & Co. Maintains Overweight on Amrize, Lowers Price Target to $54

Stephens & Co. analyst Trey Grooms maintains Amrize (NYSE:AMRZ) with a Overweight and lowers the price target from $65 to $54.

Benzinga·08:18AMRZ▲+2.9%

Citigroup Maintains Buy on Amrize, Lowers Price Target to $58

Citigroup analyst Anthony Pettinari maintains Amrize (NYSE:AMRZ) with a Buy and lowers the price target from $66 to $58.

Benzinga·11:52AMRZ▲+2.9%

RBC Capital Downgrades Amrize (AMRZ)

Fintel·11:06AMRZ▲+2.9%

Amrize Files Form 10-Q for Second Quarter 2026

CHICAGO & ZUG, Switzerland, August 10, 2026--Amrize (AMRZ) has filed its Form 10-Q for the Second Quarter and First Half Year 2026 with the U.S. Securities and Exchange Commission. The report is also available on Amrize’s website at https://investors.amrize.com/

Yahoo·16:15AMRZ▲+2.9%

Amrize's Q2 Earnings Miss, EBITDA Guidance Cut Raise Execution Concerns, RBC Capital Markets Says

Amrize's (AMRZ) Q2 earnings miss and reduced full-year adjusted EBITDA guidance showed weaker execut

Yahoo·11:59AMRZ▲+2.9%

RBC Capital Downgrades Amrize to Underperform, Lowers Price Target to $48

RBC Capital analyst Anthony Codling downgrades Amrize (NYSE:AMRZ) from Sector Perform to Underperform and lowers the price target from $60 to $48.

Benzinga·07:41AMRZ▲+2.9%

Has Amrize (SWX:AMRZ) Fallen Far Enough To Look Undervalued?

Amrize stock has slipped year to date, yet the current market price still screens as cheap on the valuation checks. This sets up a clear question over whether the recent share price weakness is creating an opportunity or simply reflecting underlying risks. So far this year, Amrize shares have declined 14.3%, which means the stock is coming into any valuation work after a period of pressure rather than strength. The long term appeal for investors can rest on Amrize converting its business...

Yahoo·22:07AMRZ▲+2.9%